This report was recently updated on November 15 2024 with the latest and most recent
market numbers
Global Peptide Sequencing Market Size, Trends & Analysis - Forecasts to 2028 By Technology (Mass Spectrometry, Edman Degradation, Next-generation Sequencing, and Others), By Product & Service (Reagents and Kits, Instruments, and Service), By Application (Drug Discovery and Development, Investigational & Clinical Research, and Other Applications), By End User (Academic Institutes & Research Centers, Pharmaceutical & Biotechnology Companies, and Others), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis
The global peptide sequencing market is estimated to exhibit a CAGR of 6.6% from 2023 to 2028.
Government financing, grants for biomedical R&D, and the growing interest in personalized medicine are the primary drivers of market growth. Drug research and discovery are the focus of many R&D projects supported by the government. A critical first step in finding possible therapeutic candidates, comprehending their modes of action, and maximizing their effectiveness is peptide sequencing. Peptide sequencing services are in high demand since the grant supports research into finding novel medicinal peptides. Additionally, government funding often targets proteomics research, which involves the study of proteins and peptides in various disease states. A crucial component of proteomics is peptide sequencing, which aids in discovering biomarkers and comprehending disease causes. For instance, a WHO report released in January 2022 states that globally 11 funders including Wellcome Trust, European and Developing Countries Clinical Trials Partnership, and others provided about 80,178 grants for biomedical research in 2019.
The increased focus on biomarker discovery and technological innovations, such as improved mass spectrometry (MS) techniques, sequencing algorithms, and data analysis software is expected to support the market growth during the forecast period. Peptide sequencing is now faster and more sensitive due to improvements in mass spectrometry (MS) methods, including electrospray ionization-mass spectrometry (ESI-MS), Quadrupole time-of-flight (Q-TOF), and MALDI-TOF. These advancements allow researchers to examine complex peptide combinations more quickly and precisely. Moreover, new techniques for preparing samples, such as enrichment and cleanup processes, have increased sample quality, lowered background noise, and improved peptide identification in intricate biological matrices. For instance, NVIDIA Corporation announced in September 2022 that it will integrate the NeMo LLM cloud service with BioNeMO. This resource provides pre-trained chemistry and biology language models to researchers. These services facilitate the manipulation of proteins and data for various purposes in research, including drug development.
The growing usage of recombinant antibodies and the rising focus on target-based drug development propel market growth. Recombinant antibodies are often used to identify peptide epitopes, specific regions on proteins, or peptides recognized by antibodies. Understanding the precise amino acid sequence of these epitopes is essential for determining the binding specificity of the antibody, and peptide sequencing assists with this process. Moreover, to ensure the accuracy and dependability of the antibody's function, peptide sequencing is utilized to verify that the antibody recognizes the targeted epitope.
With the growing field of proteomics research, there is an opportunity to provide peptide sequencing services and technologies that facilitate the discovery of therapeutic targets and biomarkers for personalized medicine. This can entail the creation of specialized medications and diagnostic tools. Additionally, AI and machine learning are increasingly used in peptide sequencing data analysis. Companies can explore opportunities to develop cutting-edge bioinformatics solutions that increase the precision and speed of data interpretation.
However, the high cost of peptide sequencing equipment and data privacy and security concerns hamper market growth.
The Edman degradation segment is expected to hold the largest share of the market. Edman degradation is a well-established and widely recognized method for sequencing peptides. It has been successfully applied for a long time in the fields of peptide sequencing and proteomics. Researchers possess a significant level of trust in its dependability and precision. Additionally, a wide variety of peptides, including those with post-translational modifications or other structural changes, can be sequenced using Edman degradation. It is not limited to specific peptide types, allowing it to address diverse research needs.
The mass spectrometry segment is expected to be the fastest-growing segment in the market from 2023-2028. Even at extremely low quantities, peptides can be detected and identified using mass spectrometry (MS), which has outstanding sensitivity and specificity. This attribute is invaluable in various research and clinical applications.
The instruments segment is expected to hold the largest share of the market. Peptide sequencing instruments are very adaptable and can be utilized in various research fields, such as drug development, clinical diagnostics, proteomics, and personalized medicine. This broad range of applications drives demand for instruments. Additionally, instruments are essential for sample preparation, analysis, and data acquisition, making them fundamental to sequencing.
The service segment is anticipated to be the fastest-growing segment in the market from 2023-2028. Peptide sequencing services are outsourced to specialized providers, such as research institutes, pharmaceutical businesses, and biotechnology organizations. This trend reflects a shift toward more cost-effective and efficient outsourcing strategies.
The drug discovery and development segment is expected to hold the largest share of the market. When determining possible drug targets, peptide sequencing is essential. Researchers' awareness of the structures and sequencing of certain peptides or proteins associated with illnesses enables them to identify potential targets for drug development. Peptide sequencing helps in understanding the pharmacokinetics and pharmacodynamics of potential drug candidates. This is essential for determining how medications enter the body and are dispersed, metabolized, and excreted.
The investigational & clinical research segment is anticipated to be the fastest-growing segment in the market from 2023-2028. Investigative and clinical research focuses on studying how medications are absorbed, transported, metabolized, and removed in the human body. Drug candidates' pharmacokinetics and pharmacodynamics are evaluated via peptide sequencing.
The academic institutes & research centers segment is expected to hold the largest share of the market. In several scientific fields, including biochemistry, molecular biology, genomics, and proteomics, peptide sequencing is an essential method. Peptide sequencing is a useful technique in academic institutions' laboratories and research centers conducting multidisciplinary research. Additionally, many academic institutions have core facilities dedicated to advanced instrumentation, including mass spectrometers and peptide sequencers. These facilities support various projects and help researchers from many disciplines.
The pharmaceutical & biotechnology companies segment is anticipated to be the fastest-growing segment in the market from 2023-2028. Companies in the biotechnology and pharmaceutical industries are heavily involved in drug discovery and development. Peptide sequencing is essential to determine possible therapeutic targets, confirm lead compounds, and describe therapeutic peptides and proteins.
North America is expected to be the largest region in the global market. The increasing adoption of next-generation sequencing (NGS) has expanded the capabilities and potential applications of peptide sequencing in proteomics research and clinical diagnostics in North America. For instance, Medicare, a government national health insurance program, released a national coverage determination (NCD) for next-generation sequencing (NGS) in March 2018 to make NGS testing more accessible to Medicare enrollees.
Asia Pacific is anticipated to witness rapid growth during the forecast period. Government organizations in the Asia Pacific region provide substantial funding for biotechnology research, such as peptide sequencing and proteomics. These grants can help companies, research groups, and academic institutions conduct innovative studies and create cutting-edge sequencing technology. For instance, In the Union Budget 2022–2023 the Department of Biotechnology was awarded USD 343.56 million (Rs. 2,581 crores) for developing genetic engineering, technologies, bioinformatics, agriculture biotechnology, and training skilled professionals, according to a May 2020 update by the India Brand Equity Foundation (IBEF).
Creative Proteomics, Biognosys Inc, Thermo Fisher Scientific, Inc., Shimadzu Corporation, Agilent Technologies, Inc., Rapid Novor, Inc., BioPharmaSpec, AltaBioscience Ltd, BioNome, MtoZ-Biolabs Inc., and Proteome Factory AG, among others, are some of the key players operating in the global peptide sequencing market.
Please note: This is not an exhaustive list of companies profiled in the report.
In June 2018, the Quadrupole time-of-flight (Q-TOF) LCMS-9030 System was introduced by Shimadzu (Japan). This aided the company in growing the range of products it offers.
In 2022, Seer introduced its platform for classifying the tens of thousands of proteins in the human body responsible for the biological processes involved in health and diseases.
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Functions
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2 TECHNOLOGICAL TRENDS
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
3 GLOBAL MARKET OUTLOOK
3.1 Market Pyramid Analysis
3.1.1 Introduction
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2 Demand Side Analysis
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market Opportunities: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3 Supply Side Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
3.3.2.1 Political Landscape
3.3.2.2 Economic Landscape
3.3.2.3 Social Landscape
3.3.2.4 Technology Landscape
3.3.3 Value Chain Analysis
3.3.4 Trend Analysis
3.3.5 Gap Analysis
3.3.6 Cost Analysis
4 GLOBAL PEPTIDE SEQUENCING MARKET, BY TECHNOLOGY
4.1 Introduction
4.2 Peptide Sequencing Market: Technology Scope Key Takeaways
4.3 Revenue Growth Analysis, 2022 & 2028
4.4 Mass Spectrometry
4.4.1 Mass Spectrometry Market Estimates and Forecast, 2020-2028 (USD Billion)
4.5 Edman Degradation
4.5.1 Edman Degradation Market Estimates and Forecast, 2020-2028 (USD Billion)
4.6 Next-generation Sequencing
4.6.1 Next-generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
4.7 Others
4.7.1 Others Market Estimates and Forecast, 2020-2028 (USD Billion)
5 GLOBAL PEPTIDE SEQUENCING MARKET, BY PRODUCT & SERVICE
5.1 Introduction
5.2 Peptide Sequencing Market: Product & Service Scope Key Takeaways
5.3 Revenue Growth Analysis, 2022 & 2028
5.4 Reagents and Kits
5.4.1 Reagents and Kits Market Estimates and Forecast, 2020-2028 (USD Billion)
5.5 Instruments
5.5.1 Instruments Market Estimates and Forecast, 2020-2028 (USD Billion)
5.6 Service
5.6.1 Service Market Estimates and Forecast, 2020-2028 (USD Billion)
6 GLOBAL PEPTIDE SEQUENCING MARKET, BY APPLICATION
6.1 Introduction
6.2 Peptide Sequencing Market: Application Scope Key Takeaways
6.3 Revenue Growth Analysis, 2022 & 2028
6.4 Drug Discovery and Development
6.4.1 Drug Discovery and Development Market Estimates and Forecast, 2020-2028 (USD Billion)
6.5 Investigational & Clinical Research
6.5.1 Investigational & Clinical Research Market Estimates and Forecast, 2020-2028 (USD Billion)
6.6 Other Applications
6.6.1 Other Applications Market Estimates and Forecast, 2020-2028 (USD Billion)
7 GLOBAL PEPTIDE SEQUENCING MARKET, BY END USER
7.1 Introduction
7.2 Peptide Sequencing Market: End User Scope Key Takeaways
7.3 Revenue Growth Analysis, 2022 & 2028
7.4 Academic Institutes & Research Centers
7.4.1 Academic Institutes & Research Centers Market Estimates and Forecast, 2020-2028 (USD Billion)
7.5 Pharmaceutical & Biotechnology Companies
7.5.1 Pharmaceutical & Biotechnology Companies Market Estimates and Forecast, 2020-2028 (USD Billion)
7.6 Others
7.6.1 Others Market Estimates and Forecast, 2020-2028 (USD Billion)
8 GLOBAL PEPTIDE SEQUENCING MARKET, BY REGION
8.1 Introduction
8.2 North America Peptide Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.2.1 By Technology
8.2.2 By Product & Service
8.2.3 By Application
8.2.4 By End User
8.2.5 By Country
8.2.5.1 U.S. Peptide Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.2.5.1.1 By Technology
8.2.5.1.2 By Product & Service
8.2.5.1.3 By Application
8.2.5.1.4 By End User
8.2.5.2 Canada Peptide Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.2.5.2.1 By Technology
8.2.5.2.2 By Product & Service
8.2.5.2.3 By Application
8.2.5.2.4 By End User
8.2.5.3 Mexico Peptide Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.2.5.3.1 By Technology
8.2.5.3.2 By Product & Service
8.2.5.3.3 By Application
8.2.5.3.4 By End User
8.3 Europe Peptide Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.3.1 By Technology
8.3.2 By Product & Service
8.3.3 By Application
8.3.4 By End User
8.3.5 By Country
8.3.5.1 Germany Peptide Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.3.5.1.1 By Technology
8.3.5.1.2 By Product & Service
8.3.5.1.3 By Application
8.3.5.1.4 By End User
8.3.5.2 U.K. Presered Flowers Market Estimates and Forecast, 2020-2028 (USD Billion)
8.3.5.2.1 By Technology
8.3.5.2.2 By Product & Service
8.3.5.2.3 By Application
8.3.5.2.4 By End User
8.3.5.3 France Peptide Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.3.5.3.1 By Technology
8.3.5.3.2 By Product & Service
8.3.5.3.3 By Application
8.3.5.3.4 By End User
8.3.5.4 Italy Peptide Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.3.5.4.1 By Technology
8.3.5.4.2 By Product & Service
8.3.5.4.3 By Application
8.3.5.4.4 By End User
8.3.5.5 Spain Peptide Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.3.5.5.1 By Technology
8.3.5.5.2 By Product & Service
8.3.5.5.3 By Application
8.3.5.5.4 By End User
8.3.5.6 Netherlands Peptide Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.3.5.6.1 By Technology
8.3.5.6.2 By Product & Service
8.3.5.6.3 By Application
8.3.5.6.4 By End User
8.3.5.7 Rest of Europe Peptide Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.3.5.7.1 By Technology
8.3.5.7.2 By Product & Service
8.3.5.7.3 By Application
8.3.5.7.4 By End User
8.4 Asia Pacific Peptide Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4.1 By Technology
8.4.2 By Product & Service
8.4.3 By Application
8.4.4 By End User
8.4.5 By Country
8.4.5.1 China Peptide Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4.5.1.1 By Technology
8.4.5.1.2 By Product & Service
8.4.5.1.3 By Application
8.4.5.1.4 By End User
8.4.5.2 Japan Peptide Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4.5.2.1 By Technology
8.4.5.2.2 By Product & Service
8.4.5.2.3 By Application
8.4.5.2.4 By End User
8.4.5.3 India Peptide Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4.5.3.1 By Technology
8.4.5.3.2 By Product & Service
8.4.5.3.3 By Application
8.4.5.3.4 By End User
8.4.5.4 South Korea Peptide Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4.5.4.1 By Technology
8.4.5.4.2 By Product & Service
8.4.5.4.3 By Application
8.4.5.4.4 By End User
8.4.5.5 Singapore Peptide Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4.5.5.1 By Technology
8.4.5.5.2 By Product & Service
8.4.5.5.3 By Application
8.4.5.5.4 By End User
8.4.5.6 Malaysia Peptide Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4.5.6.1 By Technology
8.4.5.6.2 By Product & Service
8.4.5.6.3 By Application
8.4.5.6.4 By End User
8.4.5.7 Thailand Peptide Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4.5.7.1 By Technology
8.4.5.7.2 By Product & Service
8.4.5.7.3 By Application
8.4.5.7.4 By End User
8.4.5.8 Indonesia Peptide Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4.5.8.1 By Technology
8.4.5.8.2 By Product & Service
8.4.5.8.3 By Application
8.4.5.8.4 By End User
8.4.5.9 Vietnam Peptide Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4.5.9.1 By Technology
8.4.5.9.2 By Product & Service
8.4.5.9.3 By Application
8.4.5.9.4 By End User
8.4.5.10 Taiwan Peptide Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4.5.10.1 By Technology
8.4.5.10.2 By Product & Service
8.4.5.10.3 By Application
8.4.5.10.4 By End User
8.4.5.11 Rest of Asia Pacific Peptide Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4.5.11.1 By Technology
8.4.5.11.2 By Product & Service
8.4.5.11.3 By Application
8.4.5.11.4 By End User
8.5 Middle East and Africa Peptide Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.5.1 By Technology
8.5.2 By Product & Service
8.5.3 By Application
8.5.4 By End User
8.5.5 By Country
8.5.5.1 Saudi Arabia Peptide Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.5.5.1.1 By Technology
8.5.5.1.2 By Product & Service
8.5.5.1.3 By Application
8.5.5.1.4 By End User
8.5.5.2 U.A.E. Peptide Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.5.5.2.1 By Technology
8.5.5.2.2 By Product & Service
8.5.5.2.3 By Application
8.5.5.2.4 By End User
8.5.5.3 Israel Peptide Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.5.4.3.1 By Technology
8.5.4.3.2 By Product & Service
8.5.4.3.3 By Application
8.5.5.3.4 By End User
8.5.5.4 South Africa Peptide Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.5.5.4.1 By Technology
8.5.5.4.2 By Product & Service
8.5.5.4.3 By Application
8.5.5.4.4 By End User
8.5.5.5 Rest of Middle East and Africa Peptide Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.5.5.5.1 By Technology
8.5.5.5.2 By Product & Service
8.5.5.5.2 By Application
8.5.5.5.4 By End User
8.6 Central & South America Peptide Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.6.1 By Technology
8.6.2 By Product & Service
8.6.3 By Application
8.6.4 By End User
8.6.5 By Country
8.6.5.1 Brazil Peptide Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.6.5.1.1 By Technology
8.6.5.1.2 By Product & Service
8.6.5.1.3 By Application
8.6.5.1.4 By End User
8.6.5.2 Argentina Peptide Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.6.5.2.1 By Technology
8.6.5.2.2 By Product & Service
8.6.5.2.3 By Application
8.6.5.2.4 By End User
8.6.5.3 Chile Peptide Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.6.5.3.1 By Technology
8.6.5.3.2 By Product & Service
8.6.5.3.3 By Application
8.6.5.5.4 By End User
8.6.5.4 Rest of Central & South America Peptide Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.6.5.4.1 By Technology
8.6.5.4.2 By Product & Service
8.6.5.4.3 By Application
8.6.5.4.4 By End User
9 COMPETITIVE LANDCAPE
9.1 Company Market Share Analysis
9.2 Four Quadrant Positioning Matrix
9.2.1 Market Leaders
9.2.2 Market Visionaries
9.2.3 Market Challengers
9.2.4 Niche Market Players
9.3 Vendor Landscape
9.3.1 North America
9.3.2 Europe
9.3.3 Asia Pacific
9.3.4 Rest of the World
9.4 Company Profiles
9.4.1 Creative Proteomics
9.4.1.1 Business Description & Financial Analysis
9.4.1.2 SWOT Analysis
9.4.1.3 Products & Services Offered
9.4.1.4 Strategic Alliances between Business Partners
9.4.2 Biognosys Inc
9.4.2.1 Business Description & Financial Analysis
9.4.2.2 SWOT Analysis
9.4.2.3 Products & Services Offered
9.4.2.4 Strategic Alliances between Business Partners
9.4.3 Thermo Fisher Scientific, Inc.
9.4.3.1 Business Description & Financial Analysis
9.4.3.2 SWOT Analysis
9.4.3.3 Products & Services Offered
9.4.3.4 Strategic Alliances between Business Partners
9.4.4 Shimadzu Corporation
9.4.4.1 Business Description & Financial Analysis
9.4.4.2 SWOT Analysis
9.4.4.3 Products & Services Offered
9.4.4.4 Strategic Alliances between Business Partners
9.4.5 Agilent Technologies, Inc.
9.4.5.1 Business Description & Financial Analysis
9.4.5.2 SWOT Analysis
9.4.5.3 Products & Services Offered
9.4.5.4 Strategic Alliances between Business Partners
9.4.6 RAPID NOVOR, INC.
9.4.6.1 Business Description & Financial Analysis
9.4.6.2 SWOT Analysis
9.4.6.3 Products & Services Offered
9.4.6.4 Strategic Alliances between Business Partners
9.4.7 BioPharmaSpec
9.4.7.1 Business Description & Financial Analysis
9.4.7.2 SWOT Analysis
9.4.7.3 Products & Services Offered
9.4.8.4 Strategic Alliances between Business Partners
9.4.8 AltaBioscience Ltd
9.4.8.1 Business Description & Financial Analysis
9.4.8.2 SWOT Analysis
9.4.8.3 Products & Services Offered
9.4.8.4 Strategic Alliances between Business Partners
9.4.9 BioNome
9.4.9.1 Business Description & Financial Analysis
9.4.9.2 SWOT Analysis
9.4.9.3 Products & Services Offered
9.4.9.4 Strategic Alliances between Business Partners
9.4.10 MtoZ-Biolabs Inc.
9.4.10.1 Business Description & Financial Analysis
9.4.10.2 SWOT Analysis
9.4.10.3 Products & Services Offered
9.4.10.4 Strategic Alliances between Business Partners
9.4.11 Other Companies
9.4.11.1 Business Description & Financial Analysis
9.4.11.2 SWOT Analysis
9.4.11.3 Products & Services Offered
9.4.11.4 Strategic Alliances between Business Partners
10 RESEARCH METHODOLOGY
10.1 Market Introduction
10.1.1 Market Definition
10.1.2 Market Scope & Segmentation
10.2 Information Procurement
10.2.1 Secondary Research
10.2.1.1 Purchased Databases
10.2.1.2 GMEs Internal Data Repository
10.2.1.3 Secondary Resources & Third Party Perspectives
10.2.1.4 Company Information Sources
10.2.2 Primary Research
10.2.2.1 Various Types of Respondents for Primary Interviews
10.2.2.2 Number of Interviews Conducted throughout the Research Process
10.2.2.3 Primary Stakeholders
10.2.2.4 Discussion Guide for Primary Participants
10.2.3 Expert Panels
10.2.3.1 Expert Panels Across 30+ Industry
10.2.4 Paid Local Experts
10.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
10.3 Market Estimation
10.3.1 Top-Down Approach
10.3.1.1 Macro-Economic Indicators Considered
10.3.1.2 Micro-Economic Indicators Considered
10.3.2 Bottom Up Approach
10.3.2.1 Company Share Analysis Approach
10.3.2.2 Estimation of Potential Product Sales
10.4 Data Triangulation
10.4.1 Data Collection
10.4.2 Time Series, Cross Sectional & Panel Data Analysis
10.4.3 Cluster Analysis
10.5 Analysis and Output
10.5.1 Inhouse AI Based Real Time Analytics Tool
10.5.2 Output From Desk & Primary Research
10.6 Research Assumptions & Limitations
10.7.1 Research Assumptions
10.7.2 Research Limitations
LIST OF TABLES
1 Global Peptide Sequencing Market, By Technology, 2020-2028 (USD Billion)
2 Mass Spectrometry Market, By Region, 2020-2028 (USD Billion)
3 Edman Degradation Market, By Region, 2020-2028 (USD Billion)
4 Next-generation Sequencing Market, By Region, 2020-2028 (USD Billion)
5 Others Market, By Region, 2020-2028 (USD Billion)
6 Global Peptide Sequencing Market, By Product & Service, 2020-2028 (USD Billion)
7 Reagents and Kits Market, By Region, 2020-2028 (USD Billion)
8 Instruments Market, By Region, 2020-2028 (USD Billion)
9 Service Market, By Region, 2020-2028 (USD Billion)
10 Global Peptide Sequencing Market, By Application, 2020-2028 (USD Billion)
11 Drug Discovery and Development Market, By Region, 2020-2028 (USD Billion)
12 Investigational & Clinical Research Market, By Region, 2020-2028 (USD Billion)
13 Other Applications Market, By Region, 2020-2028 (USD Billion)
14 Global Peptide Sequencing Market, By END USER, 2020-2028 (USD Billion)
15 Academic Institutes & Research Centers Market, By Region, 2020-2028 (USD Billion)
16 Pharmaceutical & Biotechnology Companies Market, By Region, 2020-2028 (USD Billion)
17 Others Market, By Region, 2020-2028 (USD Billion)
18 Regional Analysis, 2020-2028 (USD Billion)
19 North America Peptide Sequencing Market, By Technology, 2020-2028 (USD Billion)
20 North America Peptide Sequencing Market, By Product & Service, 2020-2028 (USD Billion)
21 North America Peptide Sequencing Market, By Application, 2020-2028 (USD Billion)
22 North America Peptide Sequencing Market, By End User, 2020-2028 (USD Billion)
23 North America Peptide Sequencing Market, By Country, 2020-2028 (USD Billion)
24 U.S Peptide Sequencing Market, By Technology, 2020-2028 (USD Billion)
25 U.S Peptide Sequencing Market, By Product & Service, 2020-2028 (USD Billion)
26 U.S Peptide Sequencing Market, By Application, 2020-2028 (USD Billion)
27 U.S Peptide Sequencing Market, By End User, 2020-2028 (USD Billion)
28 Canada Peptide Sequencing Market, By Technology, 2020-2028 (USD Billion)
29 Canada Peptide Sequencing Market, By Product & Service, 2020-2028 (USD Billion)
30 Canada Peptide Sequencing Market, By Application, 2020-2028 (USD Billion)
31 CANADA Peptide Sequencing Market, By End User, 2020-2028 (USD Billion)
32 Mexico Peptide Sequencing Market, By Technology, 2020-2028 (USD Billion)
33 Mexico Peptide Sequencing Market, By Product & Service, 2020-2028 (USD Billion)
34 Mexico Peptide Sequencing Market, By Application, 2020-2028 (USD Billion)
35 mexico Peptide Sequencing Market, By End User, 2020-2028 (USD Billion)
36 Europe Peptide Sequencing Market, By Technology, 2020-2028 (USD Billion)
37 Europe Peptide Sequencing Market, By Product & Service, 2020-2028 (USD Billion)
38 Europe Peptide Sequencing Market, By Application, 2020-2028 (USD Billion)
39 europe Peptide Sequencing Market, By End User, 2020-2028 (USD Billion)
40 europe Peptide Sequencing Market, By COUNTRY, 2020-2028 (USD Billion)
41 Germany Peptide Sequencing Market, By Technology, 2020-2028 (USD Billion)
42 Germany Peptide Sequencing Market, By Product & Service, 2020-2028 (USD Billion)
43 Germany Peptide Sequencing Market, By Application, 2020-2028 (USD Billion)
44 germany Peptide Sequencing Market, By End User, 2020-2028 (USD Billion)
45 UK Peptide Sequencing Market, By Technology, 2020-2028 (USD Billion)
46 UK Peptide Sequencing Market, By Product & Service, 2020-2028 (USD Billion)
47 UK Peptide Sequencing Market, By Application, 2020-2028 (USD Billion)
48 U.kPeptide Sequencing Market, By End User, 2020-2028 (USD Billion)
49 France Peptide Sequencing Market, By Technology, 2020-2028 (USD Billion)
50 France Peptide Sequencing Market, By Product & Service, 2020-2028 (USD Billion)
51 France Peptide Sequencing Market, By Application, 2020-2028 (USD Billion)
52 france Peptide Sequencing Market, By End User, 2020-2028 (USD Billion)
53 Italy Peptide Sequencing Market, By Technology, 2020-2028 (USD Billion)
54 Italy Peptide Sequencing Market, By T Product & Service Type, 2020-2028 (USD Billion)
55 Italy Peptide Sequencing Market, By Application, 2020-2028 (USD Billion)
56 italy Peptide Sequencing Market, By End User, 2020-2028 (USD Billion)
57 Spain Peptide Sequencing Market, By Technology, 2020-2028 (USD Billion)
58 Spain Peptide Sequencing Market, By Product & Service, 2020-2028 (USD Billion)
59 Spain Peptide Sequencing Market, By Application, 2020-2028 (USD Billion)
60 spain Peptide Sequencing Market, By End User, 2020-2028 (USD Billion)
61 Netherlands Peptide Sequencing Market, By Technology, 2020-2028 (USD Billion)
62 Netherlands Peptide Sequencing Market, By Product & Service, 2020-2028 (USD Billion)
63 Netherlands Peptide Sequencing Market, By Application, 2020-2028 (USD Billion)
64 Netherlands Peptide Sequencing Market, By END USER, 2020-2028 (USD Billion)
65 Rest Of Europe Peptide Sequencing Market, By Technology, 2020-2028 (USD Billion)
66 Rest Of Europe Peptide Sequencing Market, By Product & Service, 2020-2028 (USD Billion)
67 Rest of Europe Peptide Sequencing Market, By Application, 2020-2028 (USD Billion)
68 REST OF EUROPE Peptide Sequencing Market, By End User, 2020-2028 (USD Billion)
69 Asia Pacific Peptide Sequencing Market, By Technology, 2020-2028 (USD Billion)
70 Asia Pacific Peptide Sequencing Market, By Product & Service, 2020-2028 (USD Billion)
71 Asia Pacific Peptide Sequencing Market, By Application, 2020-2028 (USD Billion)
72 asia Peptide Sequencing Market, By End User, 2020-2028 (USD Billion)
73 Asia Pacific Peptide Sequencing Market, By Country, 2020-2028 (USD Billion)
74 China Peptide Sequencing Market, By Technology, 2020-2028 (USD Billion)
75 China Peptide Sequencing Market, By Product & Service, 2020-2028 (USD Billion)
76 China Peptide Sequencing Market, By Application, 2020-2028 (USD Billion)
77 china Peptide Sequencing Market, By End User, 2020-2028 (USD Billion)
78 India Peptide Sequencing Market, By Technology, 2020-2028 (USD Billion)
79 India Peptide Sequencing Market, By Product & Service, 2020-2028 (USD Billion)
80 India Peptide Sequencing Market, By Application, 2020-2028 (USD Billion)
81 india Peptide Sequencing Market, By End User, 2020-2028 (USD Billion)
82 Japan Peptide Sequencing Market, By Technology, 2020-2028 (USD Billion)
83 Japan Peptide Sequencing Market, By Product & Service, 2020-2028 (USD Billion)
84 Japan Peptide Sequencing Market, By Application, 2020-2028 (USD Billion)
85 japan Peptide Sequencing Market, By End User, 2020-2028 (USD Billion)
86 South Korea Peptide Sequencing Market, By Technology, 2020-2028 (USD Billion)
87 South Korea Peptide Sequencing Market, By Product & Service, 2020-2028 (USD Billion)
88 South Korea Peptide Sequencing Market, By Application, 2020-2028 (USD Billion)
89 south korea Peptide Sequencing Market, By End User, 2020-2028 (USD Billion)
90 Singapore Peptide Sequencing Market, By Technology, 2020-2028 (USD Billion)
91 Singapore Peptide Sequencing Market, By Product & Service, 2020-2028 (USD Billion)
92 Singapore Peptide Sequencing Market, By Application, 2020-2028 (USD Billion)
93 Singapore Peptide Sequencing Market, By End User, 2020-2028 (USD Billion)
94 Thailand Peptide Sequencing Market, By Technology, 2020-2028 (USD Billion)
95 Thailand Peptide Sequencing Market, By Product & Service, 2020-2028 (USD Billion)
96 Thailand Peptide Sequencing Market, By Application, 2020-2028 (USD Billion)
97 Thailand Peptide Sequencing Market, By End User, 2020-2028 (USD Billion)
98 MALAYSIA Peptide Sequencing Market, By Technology, 2020-2028 (USD Billion)
99 MALAYSIA Peptide Sequencing Market, By Product & Service, 2020-2028 (USD Billion)
100 MALAYSIA Peptide Sequencing Market, By Application, 2020-2028 (USD Billion)
101 MALAYSIA Peptide Sequencing Market, By End User, 2020-2028 (USD Billion)
102 Vietnam Peptide Sequencing Market, By Technology, 2020-2028 (USD Billion)
103 Vietnam Peptide Sequencing Market, By Product & Service, 2020-2028 (USD Billion)
104 Vietnam Peptide Sequencing Market, By Application, 2020-2028 (USD Billion)
105 Taiwan Peptide Sequencing Market, By Technology, 2020-2028 (USD Billion)
106 Taiwan Peptide Sequencing Market, By Product & Service, 2020-2028 (USD Billion)
107 Taiwan Peptide Sequencing Market, By Application, 2020-2028 (USD Billion)
108 Taiwan Peptide Sequencing Market, By End User, 2020-2028 (USD Billion)
109 REST OF APAC Peptide Sequencing Market, By Technology, 2020-2028 (USD Billion)
110 REST OF APAC Peptide Sequencing Market, By Product & Service, 2020-2028 (USD Billion)
111 REST OF APAC Peptide Sequencing Market, By Application, 2020-2028 (USD Billion)
112 Rest of APAC Peptide Sequencing Market, By End User, 2020-2028 (USD Billion)
113 Middle East and Africa Peptide Sequencing Market, By Technology, 2020-2028 (USD Billion)
114 Middle East and Africa Peptide Sequencing Market, By Product & Service, 2020-2028 (USD Billion)
115 Middle East and Africa Peptide Sequencing Market, By Application, 2020-2028 (USD Billion)
116 MIDDLE EAST AND AFRICA Peptide Sequencing Market, By End User, 2020-2028 (USD Billion)
117 Middle East and Africa Peptide Sequencing Market, By Country, 2020-2028 (USD Billion)
118 Saudi Arabia Peptide Sequencing Market, By Technology, 2020-2028 (USD Billion)
119 Saudi Arabia Peptide Sequencing Market, By Product & Service, 2020-2028 (USD Billion)
120 Saudi Arabia Peptide Sequencing Market, By Application, 2020-2028 (USD Billion)
121 saudi arabia Peptide Sequencing Market, By End User, 2020-2028 (USD Billion)
122 UAE Peptide Sequencing Market, By Technology, 2020-2028 (USD Billion)
123 UAE Peptide Sequencing Market, By Product & Service, 2020-2028 (USD Billion)
124 UAE Peptide Sequencing Market, By Application, 2020-2028 (USD Billion)
125 uae Peptide Sequencing Market, By End User, 2020-2028 (USD Billion)
126 Israel Peptide Sequencing Market, By Technology, 2020-2028 (USD Billion)
127 Israel Peptide Sequencing Market, By Product & Service, 2020-2028 (USD Billion)
128 Israel Peptide Sequencing Market, By Application, 2020-2028 (USD Billion)
129 Israel Peptide Sequencing Market, By End User, 2020-2028 (USD Billion)
130 South Africa Peptide Sequencing Market, By Technology, 2020-2028 (USD Billion)
131 South Africa Peptide Sequencing Market, By Product & Service, 2020-2028 (USD Billion)
132 South Africa Peptide Sequencing Market, By Application, 2020-2028 (USD Billion)
133 South Africa Peptide Sequencing Market, By End User, 2020-2028 (USD Billion)
134 REST OF MIDDLE EAST AND AFRICA Peptide Sequencing Market, By Technology, 2020-2028 (USD Billion)
135 REST OF MIDDLE EAST AND AFRICA Peptide Sequencing Market, By Product & Service, 2020-2028 (USD Billion)
136 REST OF MIDDLE EAST AND AFRICA Peptide Sequencing Market, By Application, 2020-2028 (USD Billion)
137 REST OF MIDDLE EAST AND AFRICA Peptide Sequencing Market, By End User, 2020-2028 (USD Billion)
138 Central & South America Peptide Sequencing Market, By Technology, 2020-2028 (USD Billion)
139 Central & South America Peptide Sequencing Market, By Product & Service, 2020-2028 (USD Billion)
140 Central & South America Peptide Sequencing Market, By Application, 2020-2028 (USD Billion)
141 CENTRAL & SOUTH AMERICA Peptide Sequencing Market, By End User, 2020-2028 (USD Billion)
142 Central & South America Peptide Sequencing Market, By Country, 2020-2028 (USD Billion)
143 Brazil Peptide Sequencing Market, By Technology, 2020-2028 (USD Billion)
144 Brazil Peptide Sequencing Market, By Product & Service, 2020-2028 (USD Billion)
145 Brazil Peptide Sequencing Market, By Application, 2020-2028 (USD Billion)
146 brazil Peptide Sequencing Market, By End User, 2020-2028 (USD Billion)
147 Chile Peptide Sequencing Market, By Technology, 2020-2028 (USD Billion)
148 Chile Peptide Sequencing Market, By Product & Service, 2020-2028 (USD Billion)
149 Chile Peptide Sequencing Market, By Application, 2020-2028 (USD Billion)
150 Chile Peptide Sequencing Market, By End User, 2020-2028 (USD Billion)
151 Argentina Peptide Sequencing Market, By Technology, 2020-2028 (USD Billion)
152 Argentina Peptide Sequencing Market, By Product & Service, 2020-2028 (USD Billion)
153 Argentina Peptide Sequencing Market, By Application, 2020-2028 (USD Billion)
154 Argentina Peptide Sequencing Market, By End User, 2020-2028 (USD Billion)
155 REST OF CENTRAL AND SOUTH AMERICA Peptide Sequencing Market, By Technology, 2020-2028 (USD Billion)
156 REST OF CENTRAL AND SOUTH AMERICA Peptide Sequencing Market, By Product & Service, 2020-2028 (USD Billion)
157 REST OF CENTRAL AND SOUTH AMERICA Peptide Sequencing Market, By Application, 2020-2028 (USD Billion)
158 REST OF CENTRAL AND SOUTH AMERICA Peptide Sequencing Market, By End User, 2020-2028 (USD Billion)
159 Creative Proteomics: Products & Services Offering
160 Biognosys Inc: Products & Services Offering
161 Thermo Fisher Scientific, Inc.: Products & Services Offering
162 Shimadzu Corporation: Products & Services Offering
163 Agilent Technologies, Inc.: Products & Services Offering
164 RAPID NOVOR, INC.: Products & Services Offering
165 BioPharmaSpec : Products & Services Offering
166 AltaBioscience Ltd: Products & Services Offering
167 BioNome, Inc: Products & Services Offering
168 MtoZ-Biolabs Inc.: Products & Services Offering
169 Other Companies: Products & Services Offering
LIST OF FIGURES
1 Global Peptide Sequencing Market Overview
2 Global Peptide Sequencing Market Value From 2020-2028 (USD Billion)
3 Global Peptide Sequencing Market Share, By Technology (2022)
4 Global Peptide Sequencing Market Share, By Product & Service (2022)
5 Global Peptide Sequencing Market Share, By Application (2022)
6 Global Peptide Sequencing Market Share, By End User (2022)
7 Global Peptide Sequencing Market, By Region (Asia Pacific Market)
8 Technological Trends In Global Peptide Sequencing Market
9 Four Quadrant Competitor Positioning Matrix
10 Impact Of Macro & Micro Indicators On The Market
11 Impact Of Key Drivers On The Global Peptide Sequencing Market
12 Impact Of Challenges On The Global Peptide Sequencing Market
13 Porter’s Five Forces Analysis
14 Global Peptide Sequencing Market: By Technology Scope Key Takeaways
15 Global Peptide Sequencing Market, By Technology Segment: Revenue Growth Analysis
16 Mass Spectrometry Market, By Region, 2020-2028 (USD Billion)
17 Edman Degradation Market, By Region, 2020-2028 (USD Billion)
18 Next-generation Sequencing Market, By Region, 2020-2028 (USD Billion)
19 Others Market, By Region, 2020-2028 (USD Billion)
20 Global Peptide Sequencing Market: By Product & Service Scope Key Takeaways
21 Global Peptide Sequencing Market, By Product & Service Segment: Revenue Growth Analysis
22 Reagents and Kits Market, By Region, 2020-2028 (USD Billion)
23 Instruments Market, By Region, 2020-2028 (USD Billion)
24 Service Market, By Region, 2020-2028 (USD Billion)
25 Global Peptide Sequencing Market: By Application Scope Key Takeaways
26 Global Peptide Sequencing Market, By Application Segment: Revenue Growth Analysis
27 Drug Discovery and Development Market, By Region, 2020-2028 (USD Billion)
28 Investigational & Clinical Research Market, By Region, 2020-2028 (USD Billion)
29 Other Applications Market, By Region, 2020-2028 (USD Billion)
30 Global Peptide Sequencing Market: By End User Scope Key Takeaways
31 Global Peptide Sequencing Market, By End User Segment: Revenue Growth Analysis
32 Academic Institutes & Research Centers Market, By Region, 2020-2028 (USD Billion)
33 Pharmaceutical & Biotechnology Companies Market, By Region, 2020-2028 (USD Billion)
34 Others Market, By Region, 2020-2028 (USD Billion)
35 Regional Segment: Revenue Growth Analysis
36 Global Peptide Sequencing Market: Regional Analysis
37 North America Peptide Sequencing Market Overview
38 North America Peptide Sequencing Market, By Technology
39 North America Peptide Sequencing Market, By Product & Service
40 North America Peptide Sequencing Market, By Application
41 North America Peptide Sequencing Market, By End User
42 North America Peptide Sequencing Market, By Country
43 U.S. Peptide Sequencing Market, By Technology
44 U.S. Peptide Sequencing Market, By Product & Service
45 U.S. Peptide Sequencing Market, By Application
46 U.S. Peptide Sequencing Market, By End User
47 Canada Peptide Sequencing Market, By Technology
48 Canada Peptide Sequencing Market, By Product & Service
49 Canada Peptide Sequencing Market, By Application
50 Canada Peptide Sequencing Market, By End User
51 Mexico Peptide Sequencing Market, By Technology
52 Mexico Peptide Sequencing Market, By Product & Service
53 Mexico Peptide Sequencing Market, By Application
54 Mexico Peptide Sequencing Market, By End User
55 Four Quadrant Positioning Matrix
56 Company Market Share Analysis
57 Creative Proteomics: Company Snapshot
58 Creative Proteomics: SWOT Analysis
59 Creative Proteomics: Geographic Presence
60 Biognosys Inc: Company Snapshot
61 Biognosys Inc: SWOT Analysis
62 Biognosys Inc: Geographic Presence
63 Thermo Fisher Scientific, Inc.: Company Snapshot
64 Thermo Fisher Scientific, Inc.: SWOT Analysis
65 Thermo Fisher Scientific, Inc.: Geographic Presence
66 Shimadzu Corporation: Company Snapshot
67 Shimadzu Corporation: Swot Analysis
68 Shimadzu Corporation: Geographic Presence
69 Agilent Technologies, Inc.: Company Snapshot
70 Agilent Technologies, Inc.: SWOT Analysis
71 Agilent Technologies, Inc.: Geographic Presence
72 RAPID NOVOR, INC.: Company Snapshot
73 RAPID NOVOR, INC.: SWOT Analysis
74 RAPID NOVOR, INC.: Geographic Presence
75 BioPharmaSpec : Company Snapshot
76 BioPharmaSpec : SWOT Analysis
77 BioPharmaSpec : Geographic Presence
78 AltaBioscience Ltd: Company Snapshot
79 AltaBioscience Ltd: SWOT Analysis
80 AltaBioscience Ltd: Geographic Presence
81 BioNome, Inc.: Company Snapshot
82 BioNome, Inc.: SWOT Analysis
83 BioNome, Inc.: Geographic Presence
84 MtoZ-Biolabs Inc.: Company Snapshot
85 MtoZ-Biolabs Inc.: SWOT Analysis
86 MtoZ-Biolabs Inc.: Geographic Presence
87 Other Companies: Company Snapshot
88 Other Companies: SWOT Analysis
89 Other Companies: Geographic Presence
The Global Peptide Sequencing Market has been studied from the year 2019 till 2028. However, the CAGR provided in the report is from the year 2023 to 2028. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Peptide Sequencing Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
